Lars E. French

33.0k total citations · 6 hit papers
482 papers, 21.2k citations indexed

About

Lars E. French is a scholar working on Dermatology, Oncology and Immunology. According to data from OpenAlex, Lars E. French has authored 482 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Dermatology, 126 papers in Oncology and 125 papers in Immunology. Recurrent topics in Lars E. French's work include Cutaneous lymphoproliferative disorders research (61 papers), Autoimmune Bullous Skin Diseases (52 papers) and Cutaneous Melanoma Detection and Management (52 papers). Lars E. French is often cited by papers focused on Cutaneous lymphoproliferative disorders research (61 papers), Autoimmune Bullous Skin Diseases (52 papers) and Cutaneous Melanoma Detection and Management (52 papers). Lars E. French collaborates with scholars based in Switzerland, Germany and United States. Lars E. French's co-authors include Jürg Tschopp, Pascal Schneider, Michael Hahne, Emmanuel Contassot, Michael Schröter, Donata Rimoldi, Jean-Luc Bodmer, Thomas Harr, Martin Irmler and Kay Hofmann and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Lars E. French

462 papers receiving 20.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of death receptor signals by cellular FLIP

1997 2.1k citations Lars E. French et al. profile →
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

1996 1.1k citations Lars E. French et al. profile →
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

1998 736 citations Lars E. French et al. profile →
MyD88, an Adapter Protein Involved in Interleukin-1 Signaling

1998 532 citations Lars E. French et al. profile →
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

2021 479 citations Lars E. French et al. profile →
Toxic epidermal necrolysis and Stevens-Johnson syndrome

2010 426 citations Lars E. French et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lars E. French	7.3k	6.7k	5.2k	4.4k	3.8k	482	21.2k
Thomas Ruzicka	6.2k 0.9×	5.7k 0.9×	11.9k 2.3×	3.3k 0.8×	3.8k 1.0×	672	26.2k
Juliet N. Barker	17.3k 2.4×	4.4k 0.7×	9.0k 1.7×	5.1k 1.2×	2.9k 0.8×	559	31.3k
Enrico Maggi	15.6k 2.1×	3.6k 0.5×	2.6k 0.5×	3.9k 0.9×	2.6k 0.7×	367	27.2k
Peter Valent	16.7k 2.3×	9.7k 1.5×	3.4k 0.7×	4.3k 1.0×	1.2k 0.3×	900	40.5k
Sergio Romagnani	20.6k 2.8×	4.7k 0.7×	3.3k 0.6×	4.9k 1.1×	3.7k 1.0×	350	36.0k
Brian J. Nickoloff	9.1k 1.2×	5.3k 0.8×	5.6k 1.1×	4.4k 1.0×	1.7k 0.5×	239	19.0k
J. Daniel	26.8k 3.7×	8.3k 1.2×	3.6k 0.7×	5.6k 1.3×	3.4k 0.9×	129	38.8k
Giampiero Girolomoni	12.5k 1.7×	3.1k 0.5×	9.9k 1.9×	2.5k 0.6×	2.4k 0.6×	558	23.7k
Paul E. Swanson	5.9k 0.8×	5.6k 0.8×	1.4k 0.3×	5.5k 1.2×	5.0k 1.3×	296	21.0k
Bernhard Homey	11.4k 1.6×	4.4k 0.7×	6.7k 1.3×	6.6k 1.5×	1.5k 0.4×	263	23.1k

Countries citing papers authored by Lars E. French

Since Specialization

Citations

This map shows the geographic impact of Lars E. French's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars E. French with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars E. French more than expected).

Fields of papers citing papers by Lars E. French

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars E. French. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars E. French. The network helps show where Lars E. French may publish in the future.

Co-authorship network of co-authors of Lars E. French

This figure shows the co-authorship network connecting the top 25 collaborators of Lars E. French. A scholar is included among the top collaborators of Lars E. French based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars E. French. Lars E. French is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oro, S., Lars E. French, & P. Wolkenstein. (2025). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic Strategies. Journal of Investigative Dermatology. 145(7). 1559–1561.

Hartmann, Daniela, et al.. (2024). Intraoperative PRO Score Assessment of Actinic Keratosis with FCF Fast Green-Enhanced Ex Vivo Confocal Microscopy. Applied Sciences. 14(3). 1150–1150. 5 indexed citations

Guertler, Anne, et al.. (2024). Exploring the potential of omega‐3 fatty acids in acne patients: A prospective intervention study. Journal of Cosmetic Dermatology. 23(10). 3295–3304. 5 indexed citations

Chang, Yun‐Tsan, Susanne Kimeswenger, Yi-Chien Tsai, et al.. (2024). MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature Communications. 15(1). 752–752. 5 indexed citations

Bertlich, Mattis, Daniela Hartmann, Saskia Freytag, Lars E. French, & Eva Oppel. (2024). Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications. British Journal of Dermatology. 191(6). 1000–1007. 3 indexed citations

Silverberg, Jonathan I., Lawrence F. Eichenfield, Andrew Blauvelt, et al.. (2024). 693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS). British Journal of Dermatology. 191(Supplement_2). 1 indexed citations

Pyrgidis, Nikolaos, Stephan Ledderose, Alexander Kretschmer, et al.. (2023). Characterization of Human Papilloma Virus in Prostate Cancer Patients Undergoing Radical Prostatectomy—A Prospective Study of 140 Patients. Viruses. 15(6). 1264–1264.

Plewig, Gerd, Lars E. French, Thomas Ruzicka, Roland Kaufmann, & Michael Hertl. (2022). Braun-Falco´s Dermatology. 8 indexed citations

Schmidt, Veronika, Stephan Traidl, Reihane Ziadlou, et al.. (2022). Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation. Allergy. 78(5). 1280–1291. 3 indexed citations

10.

Läuchli, Severin, Lars E. French, Emmanuella Guenova, et al.. (2021). Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring. Viruses. 13(7). 1232–1232. 5 indexed citations

11.

Kurgyis, Zsuzsanna, Larsen Vornholz, Konstanze Pechloff, et al.. (2021). Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation. Science Immunology. 6(65). eabi4425–eabi4425. 10 indexed citations

12.

Tusup, Marina, Phil F. Cheng, Ernesto Picardi, et al.. (2021). Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA. 7(1). 5–5. 3 indexed citations

13.

John, Swen Malte, Claus Garbe, Lars E. French, et al.. (2020). Improved protection of outdoor workers from solar ultraviolet radiation: position statement. Journal of the European Academy of Dermatology and Venereology. 35(6). 1278–1284. 25 indexed citations

14.

Conrad, Curdin, Jérémy Di Domizio, Alessio Mylonas, et al.. (2017). TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nature Communications. 9(1). 196 indexed citations

15.

Enk, Alexander, Eva Hadaschik, Rüdiger Eming, et al.. (2016). European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology. Journal of the European Academy of Dermatology and Venereology. 30(10). 1657–1669. 41 indexed citations

16.

Maul, Julia‐Tatjana, Florian Anzengruber, Andrew Pink, et al.. (2016). Impact of UVA on pruritus during UVA /B phototherapy of inflammatory skin diseases: a randomized double‐blind study. Journal of the European Academy of Dermatology and Venereology. 31(7). 1208–1213. 14 indexed citations

17.

Bouchaud, Grégory, Samuel Gehrke, Carsten Krieg, et al.. (2013). Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man. The Journal of Experimental Medicine. 210(10). 2105–2117. 54 indexed citations

18.

Conzett, Katrin Baumann, Marie Zipser, Valérie Enderlin, et al.. (2010). Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibition Results in Biphasic Alteration of Epidermal Homeostasis with Keratinocytic Apoptosis and Pigmentation Disorders. Clinical Cancer Research. 16(3). 1058–1064. 49 indexed citations

19.

Contassot, Emmanuel, Magali Irla, Stéphanie Hugues, et al.. (2008). Direct Presentation of a Melanocyte-Associated Antigen in Peripheral Lymph Nodes Induces Cytotoxic CD8+ T Cells. Cancer Research. 68(20). 8410–8418. 10 indexed citations

20.

Preynat‐Seauve, Olivier, et al.. (2007). Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process. Cancer Research. 67(10). 5009–5016. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact